Research

RADICAVA ORS
Blog Post

FDA Approves MTPA’s RADICAVA ORS for Treatment of ALS

By Sujatha Gurunathan | May 13, 2022
Scientific conference speakers
Featured Article

A Successful In-Person Conference

By MDA Staff | May 13, 2022
Blog Post

Brain-Computer Interface Technology Could Improve Life for Millions

By Larry Luxner | May 9, 2022
Blog Post

Simply Stated: Inclusion Body Myositis, Revisited

By Sujatha Gurunathan | April 27, 2022
Blog Post

Promoting Diversity in Rare Disease Research

By Larry Luxner | April 8, 2022
MG clinical trial
Blog Post

Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults Living with gMG

By MDA Staff | April 6, 2022
dermatomyositis clinical trial
Blog Post

Clinical Trial Alert: Phase 2 Study of Ravulizumab (Ultomiris) in Adults Living with Dermatomyositis

By MDA Staff | April 5, 2022
Blog Post

Simply Stated: What is Myotonic Dystrophy?

By Sujatha Gurunathan | March 24, 2022
Blog Post

2022 Clinical & Scientific Conference March 15 Highlights

By Sujatha Gurunathan | March 15, 2022
Clinical & Scientific Conference
Blog Post

2022 Clinical & Scientific Conference March 14 Highlights

By Sujatha Gurunathan | March 14, 2022